myAbbVie Assist ( Free medication for qualifying patients).
Biosimilars are FDA-approved, clinically equivalent versions of Humira that cost significantly less.
Most eligible patients can pay as little as $0 per month .
Groups like the PAN Foundation or HealthWell Foundation offer grants to help cover copays for specific autoimmune conditions. 4. Pharmacy Pricing & Comparison
Switching to biosimilars like Hadlima or Hyrimoz (saving $4,000+ per month ). 1. Use Manufacturer Savings Programs (Primary Choice)
HUMIRA Complete Savings Card (as low as $0–$5/month ).
Brand-name Humira can cost over $7,000 for a one-month supply without insurance. In contrast, biosimilars like Hadlima cost roughly $1,038 , and unbranded versions via GoodRx can be as low as $550 .
If your pharmacy doesn't accept the card directly, you can pay upfront and request a rebate through HUMIRA Complete to bring your final cost back down to $0. 2. Switch to Biosimilars (The "Generic" Alternative)
myAbbVie Assist ( Free medication for qualifying patients).
Biosimilars are FDA-approved, clinically equivalent versions of Humira that cost significantly less.
Most eligible patients can pay as little as $0 per month . where to buy humira cheap
Groups like the PAN Foundation or HealthWell Foundation offer grants to help cover copays for specific autoimmune conditions. 4. Pharmacy Pricing & Comparison
Switching to biosimilars like Hadlima or Hyrimoz (saving $4,000+ per month ). 1. Use Manufacturer Savings Programs (Primary Choice) myAbbVie Assist ( Free medication for qualifying patients)
HUMIRA Complete Savings Card (as low as $0–$5/month ).
Brand-name Humira can cost over $7,000 for a one-month supply without insurance. In contrast, biosimilars like Hadlima cost roughly $1,038 , and unbranded versions via GoodRx can be as low as $550 . Groups like the PAN Foundation or HealthWell Foundation
If your pharmacy doesn't accept the card directly, you can pay upfront and request a rebate through HUMIRA Complete to bring your final cost back down to $0. 2. Switch to Biosimilars (The "Generic" Alternative)
